Report #2846893

Received Jun 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: NV
Recovered: Unknown
Vaccinated: Jun 13, 2025
Onset: Jun 13, 2025
Days to onset: 0
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC15	PNEUMO (VAXNEUVANCE)	MERCK & CO. INC.	5	Z003633	OT
PNC15	PNEUMO (VAXNEUVANCE)	MERCK & CO. INC.	UNK	—	OT

Symptoms (2)

Extra dose administeredNo adverse event

Symptom narrative

No additional AE; extra dose of VAXNEUVANCE; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patient was vaccinated with Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE) Suspension for injection (dose, route of administration, lot # and expiration date were not reported) as prophylaxis and completed 4-dose series. Then, on 13-Jun-2025, the patient was inadvertently administered an extra dose of this vaccine (lot #Z003633, expiration date: 24-May-2027) (dose and route of administration were not reported) also as prophylaxis (Extra dose administered). The patient did not report any symptoms (No adverse event).